FTLF · XBRL financial data

Fitlife Brands financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (FTLF's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24†Dec 31, 2024	Q1 FY25†Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cost of goods and services sold	8,206	7,936*	9,262	9,350	8,976	8,801*	9,062	9,223	14,749	16,971*	15,808	16,738
Gross profit	5,696	—	7,287	7,580	7,001	—	6,874	6,904	8,736	—	9,517	9,811
Selling, general and administrative	3,172	3,403*	3,736	2,528	2,645	2,291*	2,512	2,485	4,105	4,934*	4,963	4,755
Total operating expenses	3,226	3,541*	3,906	3,905	3,819	3,331*	3,916	4,386	6,418	6,671*	6,456	6,456
Operating income (loss)	2,470	1,822*	3,381	3,675	3,182	2,881*	2,958	2,518	2,318	2,268*	3,061	3,355
Interest income	—	—	—	—	—	year only	—	—	—	year only	—	—
Interest expense	249	427*	414	345	326	282*	244	225	580	814*	735	679
Income tax expense (benefit)	434	217*	807	729	770	581*	701	631	829	(258)*	627	734
Net income (loss)	1,696	1,480*	2,160	2,628	2,126	2,070*	2,018	1,747	921	1,640*	1,720	1,950
Earnings per share, basic‡ USD per share	0.19	—	0.24	0.29	0.23	—	0.22	0.19	0.10	0.17*	0.18	0.21
Earnings per share, diluted‡ USD per share	0.18	—	0.22	0.27	0.22	—	0.20	0.18	0.09	0.16*	0.17	0.20
Weighted average shares, basic‡ thousands of shares	8,892	—	9,196	9,196	9,196	—	9,213	9,389	9,391	9,393*	9,391	9,391
Weighted average shares, diluted‡ thousands of shares	9,782	—	10,060	9,900	9,930	—	9,926	9,961	9,997	10,023*	9,991	9,907

‡ Per-share figures and share counts are adjusted for the 2-for-1 stock split (February 2025); filings made before it reported them unadjusted.
† Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/2 in the period ending 2025-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (FTLF's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24†Dec 31, 2024	Q1 FY25†Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	7,343	1,139	2,540	3,680	4,664	4,468	5,941	1,530	3,512	1,646	1,192	1,089
Accounts receivable	1,428	2,046	2,269	2,498	2,008	1,626	2,693	2,488	9,640	8,765	7,778	6,977
Inventory	7,724	9,091	8,869	9,779	10,371	11,074	12,131	11,722	22,227	21,324	21,528	21,070
Prepaid and other current assets	787	639	451	911	942	898	941	1,382	2,021	1,334	1,142	1,414
Total current assets	19,527	14,693	14,992	17,034	18,099	18,143	21,759	22,177	37,400	33,069	31,640	30,550
Property and equipment, net	199	137	121	106	91	75	89	81	135	128	106	78
Right-of-use asset	141	121	96	73	431	412	385	367	785	682	581	481
Goodwill	13,321	13,294	13,340	13,108	13,130	13,022	13,035	13,116	19,366	19,393	19,363	19,333
Total assets	43,972	55,346	55,486	57,311	58,587	58,531	62,193	62,847	109,984	106,320	104,269	102,592
Accounts payable	2,379	3,261	3,978	4,309	4,078	4,067	5,275	4,940	9,148	6,911	6,451	6,614
Current portion of long-term debt	2,500	—	—	—	—	4,500	—	—	14,094	—	—	—
Total current liabilities	7,388	10,337	11,828	12,323	12,055	11,311	13,296	12,968	33,025	21,610	20,812	20,913
Long-term debt	8,750	15,509	11,894	10,778	9,664	8,550	7,436	6,321	32,363	—	—	—
Lease liability, non-current	59	51	34	25	352	331	312	299	385	272	258	243
Total liabilities	18,723	28,310	26,109	25,455	24,429	22,405	23,275	21,928	68,092	62,681	58,888	55,218
Retained earnings (accumulated deficit)	(4,897)	(3,417)	(1,257)	1,371	3,497	5,567	7,585	9,332	10,253	11,893	13,613	15,563
Total stockholders' equity	25,249	27,036	29,377	31,856	34,158	36,126	38,918	40,919	41,892	43,639	45,381	47,374
Total liabilities and equity	43,972	55,346	55,486	57,311	58,587	58,531	62,193	62,847	109,984	106,320	104,269	102,592
Common shares outstanding (cover page)‡ thousands of shares	9,179	9,196	9,196	9,196	9,196	18,437	9,391	9,391	9,391	9,391	9,391	9,391

‡ Per-share figures and share counts are adjusted for the 2-for-1 stock split (February 2025); filings made before it reported them unadjusted.
† Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/2 in the period ending 2025-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (FTLF's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24†Dec 31, 2024	Q1 FY25†Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	1,696	1,480*	2,160	2,628	2,126	2,070*	2,018	1,747	921	1,640*	1,720	1,950
Depreciation and amortization	22*	30*	36	27*	22*	23*	19	14*	136*	251*	248	252*
Net cash from operating activities	978*	1,448*	5,036	1,570*	2,047*	957*	2,328	1,195*	3,672*	244*	2,484	3,635*
Purchases of property and equipment	6*	46*	10	0*	0*	0*	24	5*	8*	5*	0	0*
Net cash from investing activities	(1,831)*	(17,009)*	(10)	0*	0*	0*	(24)	(5,005)*	(37,508)*	(5)*	0	0*
Share repurchases	—	year only	—	—	—	—	—	—	—	—	—	—
Proceeds from long-term debt	0*	10,000*	0	0*	0*	0*	—	—	—	0*	—	—
Repayments of long-term debt	625*	1,125*	3,625	1,125*	1,125*	1,125*	1,125	1,125*	0*	—	—	—
Net cash from financing activities	(625)*	9,046*	(3,625)	(1,125)*	(1,125)*	(1,108)*	(866)	(702)*	35,577*	(1,923)*	(2,924)	(3,723)*
Net change in cash	(1,521)*	(6,414)*	1,392	445*	985*	(200)*	1,474	(4,409)*	1,927*	(1,866)*	(454)	(103)*

† Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 1/2 in the period ending 2025-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Fitlife Brands	1,089	not reported	3,635*	9.4M	—	Q2 FY26 10-QJun 30, 2026
Immucell	8,860	7,186	3,019*	9.1M	—	Q2 FY26 10-QJun 30, 2026
Cue Biopharma	17,392	7,877	(29,004)*	7.3M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Avalo Therapeutics	85,382	not reported	(19,988)*	53.6M	20.0 quarters	Q2 FY26 10-QJun 30, 2026
Precision Biosciences	86,076	0	(13,442)*	27.6M	6.5 quarters	Q2 FY26 10-QJun 30, 2026
Opus Genetics	88,812	755	(11,950)*	83.2M	7.4 quarters	Q2 FY26 10-QJun 30, 2026
Acumen Pharmaceuticals	53,075	not reported	(26,653)*	72.3M	3.4 quarters	Q3 FY26 10-QSep 30, 2026
iBio	56,395	0*	(6,228)*	64.3M	14.1 quarters	Q4 FY26 10-KJun 30, 2026
Fortress Biotech	196,576	18,718	(59,277)*	33.3M	3.3 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.